Uncategorized

Uncategorized

New Releases from NCBI BookshelfOptimizing Public–Private Partnerships for Clinical Cancer Research: Proceedings of a Workshop [Prepublication Draft].​Optimizing Public–Private Partnerships for Clinical Cancer Research: Proceedings of a Workshop [Prepublication Draft].

Public-private partnerships (PPPs) are collaborations among public and private entities (e.g., government agencies, research institutions, nonprofit organizations, and industry organizations)

Uncategorized

New Releases from NCBI BookshelfBenchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors [Internet].​Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors [Internet].

For patients with diabetes, hemoglobin A1c(HbA1c)treatment goals are based primarily on evaluating the outcomes and responses of the average patient.

Uncategorized

New Releases from NCBI BookshelfElranatamab (Elrexfio): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody, and who have demonstrated disease progression on the last therapy [Internet].​Elranatamab (Elrexfio): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least 3 prior lines of therapy including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody, and who have demonstrated disease progression on the last therapy [Internet].

CADTH recommends that Elrexfio should be reimbursed by public drug plans for the treatment of adult patients with relapsed or

Scroll to Top